The periprocedural management of novel oral anticoagulants in patients with nonvalvular atrial fibrillation: rationale and a summary of the available evidence from phase 3 clinical trials

American Heart Journal
Arun KrishnamoorthyRichard C Becker

Abstract

The novel oral anticoagulants (NOACs) have rapidly emerged as an alternative therapy to warfarin. Several recent phase 3 randomized control trials have demonstrated the efficacy and safety of the NOACs in the treatment for patients with nonvalvular atrial fibrillation. As the NOACs are incorporated in clinical practice, questions have begun to arise concerning their optimal use in commonly encountered situations. In this review, we provide a summary of the available evidence from the phase 3 randomized control trials specifically with regard to 1 such scenario, the periprocedural management of NOACs, with a goal of providing guidance for practicing clinicians.

References

Aug 22, 2008·Current Medical Research and Opinion·Dagmar KubitzaWolfgang Mueck
Oct 4, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Nirmala RaghavanDonglu Zhang
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Jan 1, 2010·The New England Journal of Medicine·Donald Stuart Houston, Ryan Zarychanski
Jun 12, 2010·Thrombosis and Haemostasis·Ingo AhrensKarlheinz Peter
Sep 17, 2010·Therapeutic Drug Monitoring·Edelgard Lindhoff-LastTheodore E Spiro
Feb 10, 2011·Circulation. Cardiovascular Quality and Outcomes·Lesli E SkolarusDevin L Brown
May 19, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sam Schulman, Ammar Majeed
Jul 2, 2011·Stroke; a Journal of Cerebral Circulation·Joseph P BroderickDawn O Kleindorfer
Jul 7, 2011·Journal of Thrombosis and Haemostasis : JTH·M LeviP W Kamphuisen
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Sep 20, 2011·Cardiovascular Drugs and Therapy·Jonathan P PicciniRichard C Becker
Feb 7, 2012·The American Journal of Medicine·Joanne van RynAndreas Clemens
Mar 2, 2012·The New England Journal of Medicine·Paul HarperEileen Merriman
Apr 25, 2012·Journal of Thrombosis and Thrombolysis·Robert W HarrisonRichard C Becker
Aug 31, 2012·Blood·Alex C Spyropoulos, James D Douketis
Jan 31, 2013·The American Journal of Cardiology·Christopher P RowleyMichael R Gold
Mar 12, 2013·Blood·Felix SchieleTobias Litzenburger
Mar 19, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Paul M PalevskySteven D Weisbord
Jul 25, 2014·BMJ : British Medical Journal·Blake Charlton, Rita Redberg
Nov 5, 2014·JAMA Internal Medicine·Rita F Redberg
Nov 29, 2014·Expert Review of Cardiovascular Therapy·Sophie Vanden DaelenErik Vandermeulen

❮ Previous
Next ❯

Citations

Jun 15, 2016·American Heart Journal·James A ReiffelUNKNOWN Cardiac Safety Research Consortium presenters and participants

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.